v3.25.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2022   230,706        
Beginning balance at Jan. 31, 2022 $ 1,037,643 $ 115 $ 1,991,807 $ (964,918) $ (1,240) $ 11,879
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   1,032        
Issuance of common stock upon exercise of options 8,655 $ 3 8,652      
Issuance of common stock under RSU and PSU release (in shares)   3,444        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   517        
Issuance of common stock under employee stock purchase plan 59,419   59,419      
Issuance of common stock for restricted stock awards (in shares)   6        
Vesting of early exercised options 2,204   2,204      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   72        
Issuance of common stock for founders holdbacks related to acquisitions 10,645   10,645      
Stock-based compensation expense, net of founder revest 519,735   519,735      
Capitalized stock-based compensation 20,193   20,193      
Fair value of replacement equity awards attributable to pre-acquisition service 50   50      
Net income (loss) (182,285)     (183,245)   960
Non-controlling interest 10,954         10,954
Other comprehensive income (loss) 221       221  
Ending balance (in shares) at Jan. 31, 2023   235,777        
Ending balance at Jan. 31, 2023 1,487,434 $ 118 2,612,705 (1,148,163) (1,019) 23,793
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   1,146        
Issuance of common stock upon exercise of options 8,695 $ 2 8,693      
Issuance of common stock under RSU and PSU release (in shares)   4,041        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   747        
Issuance of common stock under employee stock purchase plan 76,375 $ 1 76,374      
Issuance of common stock for restricted stock awards (in shares)   125        
Vesting of early exercised options 0          
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   27        
Issuance of common stock for founders holdbacks related to acquisitions 4,314   4,314      
Issuance of common stock for payment of board of director fees (in shares)   2        
Issuance of common stock for payment of board of director fees 344   344      
Stock-based compensation expense, net of founder revest 626,861   626,861      
Capitalized stock-based compensation 34,385   34,385      
Fair value of replacement equity awards attributable to pre-acquisition service 652   652      
Net income (loss) 90,585     89,327   1,258
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) (644)       (644)  
Ending balance (in shares) at Jan. 31, 2024   241,865        
Ending balance at Jan. 31, 2024 $ 2,337,089 $ 121 3,364,328 (1,058,836) (1,663) 33,139
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 514 514        
Issuance of common stock upon exercise of options $ 3,983   3,983      
Issuance of common stock under RSU and PSU release (in shares)   4,552        
Issuance of common stock under RSU and PSU release 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   858        
Issuance of common stock under employee stock purchase plan 99,616   99,616      
Issuance of common stock for restricted stock awards (in shares)   72        
Vesting of early exercised options 0          
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   11        
Issuance of common stock for founders holdbacks related to acquisitions 3,555   3,555      
Issuance of common stock for payment of board of director fees 348   348      
Stock-based compensation expense, net of founder revest 857,129   857,129      
Capitalized stock-based compensation 36,959   36,959      
Fair value of replacement equity awards attributable to pre-acquisition service 1,155   1,155      
Net income (loss) (16,596)     (19,271)   2,675
Non-controlling interest 3,609         3,609
Other comprehensive income (loss) (7,930)       (7,930)  
Ending balance (in shares) at Jan. 31, 2025   247,872        
Ending balance at Jan. 31, 2025 $ 3,318,917 $ 124 $ 4,367,070 $ (1,078,107) $ (9,593) $ 39,423